Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
Provided By GlobeNewswire
Last update: Nov 14, 2024
Revenue Increased 17% Quarter over Quarter
Operating Loss Decreased 27%
Management to Host Conference Call Today at 5:00 pm ET
Read more at globenewswire.com
